• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外循环期间的肝素治疗。I. 现有肝素方案中存在的问题。

Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.

作者信息

Bull B S, Korpman R A, Huse W M, Briggs B D

出版信息

J Thorac Cardiovasc Surg. 1975 May;69(5):674-84.

PMID:1127966
Abstract

Five heparin protocols, representative of about 30 presently used throughout the country, were analyzed. The adequacy of anticoagulation during and the precision of protamine neutralization at the conclusion of extracorporeal circulation were studied. In each of 50 patient's age, height, weight, or surface area was of no help in predicting heparin kinetics. The study group consisted of the 2 patients with the longest and the 2 patients with the shortest heparin half lives, as well as the 2 patients who showed the greatest sensitivity to heparin and the 2 who showed the least. By computer simulation, each was managed according to the five protocols and by a monitoring procedure. The protocols failed to provide safe anticoagulation or precise protamine neutralization, whereas the simplified monitoring approach was uniformly successful.

摘要

对全国目前使用的约30种肝素方案中的5种进行了分析。研究了体外循环期间抗凝的充分性以及体外循环结束时鱼精蛋白中和的精确性。在50名患者中,年龄、身高、体重或体表面积对预测肝素动力学均无帮助。研究组包括肝素半衰期最长的2名患者、最短的2名患者、对肝素敏感性最高的2名患者以及最低的2名患者。通过计算机模拟,按照这5种方案并采用一种监测程序对每名患者进行处理。这些方案未能提供安全的抗凝或精确的鱼精蛋白中和,而简化的监测方法则始终成功。

相似文献

1
Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.体外循环期间的肝素治疗。I. 现有肝素方案中存在的问题。
J Thorac Cardiovasc Surg. 1975 May;69(5):674-84.
2
Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.体外循环期间的肝素治疗。II. 使用剂量反应曲线个体化肝素和鱼精蛋白剂量。
J Thorac Cardiovasc Surg. 1975 May;69(5):685-9.
3
Heparin administration during extracorporeal circulation: heparin rebound and postoperative bleeding.
J Thorac Cardiovasc Surg. 1979 Jul;78(1):95-102.
4
Complications of heparin therapy.肝素治疗的并发症。
Surg Gynecol Obstet. 1975 May;140(5):789-96.
5
Predictive value of preoperative in vitro and in vivo studies for correct individual heparinization in cardiac surgery.术前体外和体内研究对心脏手术中正确个体化肝素化的预测价值。
J Thorac Cardiovasc Surg. 1979 Jul;78(1):87-94.
6
[Heparin-protamine-protocol].[肝素-鱼精蛋白方案]
Nihon Geka Hokan. 1997 May 1;66(2):49-50.
7
Control of heparin therapy in open-heart surgery.心脏直视手术中肝素治疗的控制
J Thorac Cardiovasc Surg. 1974 Jan;67(1):133-41.
8
[Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].[全膝关节置换术后低分子肝素与华法林联合抗凝治疗的并发症及风险——我们的经验]
Acta Chir Orthop Traumatol Cech. 2004;71(4):237-44.
9
[Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
Anesteziol Reanimatol. 1981 Sep-Oct(5):52-6.
10
[Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].[应用活化凝血时间控制体外循环中的临时抗凝]
Anaesthesist. 1984 Dec;33(12):588-91.

引用本文的文献

1
Heparin resistance management during cardiac surgery: a literature review and future directions.心脏手术期间肝素抵抗的管理:文献综述及未来方向。
J Extra Corpor Technol. 2024 Sep;56(3):136-144. doi: 10.1051/ject/2024015. Epub 2024 Sep 20.
2
Comparison of Blood Concentration and Weight-Based Heparin and Protamine Dosing Strategies for Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis.体外循环中基于血药浓度和体重的肝素与鱼精蛋白给药策略的比较:一项系统评价和荟萃分析
Cureus. 2024 Feb 13;16(2):e54144. doi: 10.7759/cureus.54144. eCollection 2024 Feb.
3
Utility and safety of nafamostat mesilate for anticoagulation in dogs.
甲磺酸萘莫司他在犬抗凝中的效用和安全性。
Vet Med Sci. 2023 Jan;9(1):68-75. doi: 10.1002/vms3.1002. Epub 2022 Nov 21.
4
Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery.成人心脏手术体外循环期间的肝素抵抗。
J Cardiothorac Vasc Anesth. 2022 Nov;36(11):4150-4160. doi: 10.1053/j.jvca.2022.06.021. Epub 2022 Jun 24.
5
Activated clotting time in inpatient diagnostic and interventional settings.住院诊断和介入治疗环境中的激活凝血时间。
J Thromb Thrombolysis. 2022 Nov;54(4):660-668. doi: 10.1007/s11239-022-02672-y. Epub 2022 Jun 22.
6
"In Less than No Time": Feasibility of Rotational Thromboelastometry to Detect Anticoagulant Drugs Activity and to Guide Reversal Therapy.“转眼间”:旋转血栓弹力图检测抗凝药物活性及指导逆转治疗的可行性
J Clin Med. 2022 Mar 4;11(5):1407. doi: 10.3390/jcm11051407.
7
A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients.一项比较标准激活凝血时间肝素管理与高目标激活凝血时间和个体化 Hepcon HMS 肝素管理在体外循环心脏手术患者中的盲法随机试验。
Ann Thorac Cardiovasc Surg. 2022 Jun 20;28(3):204-213. doi: 10.5761/atcs.oa.21-00222. Epub 2021 Dec 22.
8
Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site.测量心脏导管检查和 PCI 期间的活化凝血时间:采样部位的影响。
J Interv Cardiol. 2021 Sep 11;2021:4091289. doi: 10.1155/2021/4091289. eCollection 2021.
9
Clinical monitoring of activated clotting time during cardiothoracic surgery: comparing the Hemochron Response and Hemochron Signature Elite.心胸外科手术中激活凝血时间的临床监测:比较 Hemochron Response 和 Hemochron Signature Elite。
Perfusion. 2023 Mar;38(2):285-291. doi: 10.1177/02676591211049316. Epub 2021 Oct 1.
10
Patients Submitted to Myocardial Revascularization with the Use of Bilateral Internal Thoracic Arteries: Diabetics vs. Non-Diabetics.接受双侧内乳动脉进行心肌血管重建的患者:糖尿病患者与非糖尿病患者比较。
Braz J Cardiovasc Surg. 2021 Aug 6;36(4):500-505. doi: 10.21470/1678-9741-2020-0292.